BridgeBio Pharma Stock Forecast - 20 Period Moving Average
| BBIO Stock | USD 27.49 1.05 3.97% |
The 20 Period Moving Average forecasted value of BridgeBio Pharma on the next trading day is expected to be 25.07 with a mean absolute deviation of 1.14 and the sum of the absolute errors of 46.76. BridgeBio Stock Forecast is based on your current time horizon. Although BridgeBio Pharma's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of BridgeBio Pharma's systematic risk associated with finding meaningful patterns of BridgeBio Pharma fundamentals over time.
BridgeBio |
BridgeBio Pharma 20 Period Moving Average Price Forecast For the 29th of November
Given 90 days horizon, the 20 Period Moving Average forecasted value of BridgeBio Pharma on the next trading day is expected to be 25.07 with a mean absolute deviation of 1.14, mean absolute percentage error of 1.82, and the sum of the absolute errors of 46.76.Please note that although there have been many attempts to predict BridgeBio Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that BridgeBio Pharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
BridgeBio Pharma Stock Forecast Pattern
| Backtest BridgeBio Pharma | BridgeBio Pharma Price Prediction | Buy or Sell Advice |
BridgeBio Pharma Forecasted Value
In the context of forecasting BridgeBio Pharma's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. BridgeBio Pharma's downside and upside margins for the forecasting period are 21.38 and 28.75, respectively. We have considered BridgeBio Pharma's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the 20 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of BridgeBio Pharma stock data series using in forecasting. Note that when a statistical model is used to represent BridgeBio Pharma stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 81.9543 |
| Bias | Arithmetic mean of the errors | 0.1694 |
| MAD | Mean absolute deviation | 1.1405 |
| MAPE | Mean absolute percentage error | 0.0458 |
| SAE | Sum of the absolute errors | 46.7595 |
Predictive Modules for BridgeBio Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as BridgeBio Pharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for BridgeBio Pharma
For every potential investor in BridgeBio, whether a beginner or expert, BridgeBio Pharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. BridgeBio Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in BridgeBio. Basic forecasting techniques help filter out the noise by identifying BridgeBio Pharma's price trends.View BridgeBio Pharma Related Equities
| Risk & Return | Correlation |
BridgeBio Pharma Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of BridgeBio Pharma's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of BridgeBio Pharma's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
BridgeBio Pharma Market Strength Events
Market strength indicators help investors to evaluate how BridgeBio Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading BridgeBio Pharma shares will generate the highest return on investment. By undertsting and applying BridgeBio Pharma stock market strength indicators, traders can identify BridgeBio Pharma entry and exit signals to maximize returns.
BridgeBio Pharma Risk Indicators
The analysis of BridgeBio Pharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in BridgeBio Pharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting bridgebio stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.75 | |||
| Semi Deviation | 2.72 | |||
| Standard Deviation | 3.95 | |||
| Variance | 15.59 | |||
| Downside Variance | 8.27 | |||
| Semi Variance | 7.4 | |||
| Expected Short fall | (3.45) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with BridgeBio Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BridgeBio Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BridgeBio Pharma will appreciate offsetting losses from the drop in the long position's value.Moving against BridgeBio Stock
| 0.46 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
| 0.35 | OPT | Opthea | PairCorr |
| 0.35 | NAMS | NewAmsterdam Pharma | PairCorr |
The ability to find closely correlated positions to BridgeBio Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BridgeBio Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BridgeBio Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BridgeBio Pharma to buy it.
The correlation of BridgeBio Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BridgeBio Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BridgeBio Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BridgeBio Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Historical Fundamental Analysis of BridgeBio Pharma to cross-verify your projections. To learn how to invest in BridgeBio Stock, please use our How to Invest in BridgeBio Pharma guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BridgeBio Pharma. If investors know BridgeBio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BridgeBio Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.42) | Revenue Per Share 1.194 | Quarterly Revenue Growth (0.33) | Return On Assets (0.49) | Return On Equity (17.90) |
The market value of BridgeBio Pharma is measured differently than its book value, which is the value of BridgeBio that is recorded on the company's balance sheet. Investors also form their own opinion of BridgeBio Pharma's value that differs from its market value or its book value, called intrinsic value, which is BridgeBio Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BridgeBio Pharma's market value can be influenced by many factors that don't directly affect BridgeBio Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BridgeBio Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if BridgeBio Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BridgeBio Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.